Welcome to the University of Maryland Marlene and Stewart Greenebaum Cancer Center, a premier cancer and research treatment center at the University of Maryland, Baltimore.
At UMGCC, we pride ourselves in providing outstanding patient care, with an emphasis on the multi-disciplinary approach to diagnosis and treatment. Teams consisting of medical oncologists, surgeons, radiation oncologists, pathologists, radiologists, nurses and others work together to bring compassionate and cutting-edge care to our patients.
In recent years, we have seen an explosive growth of knowledge in the field of cancer research. At UMGCC, translational research is a top priority with scientists working together with clinicians to facilitate the translation of scientific progress into clinical advances. One outstanding example of the research at UMGCC is the work of Dr. Angela Brodie who developed the first aromatase inhibitor here at Maryland. These drugs have been the most important recent advance in the treatment of breast cancer, dramatically improving outcomes for women worldwide. She has been honored for this pioneering work by the prestigious Kettering and Landon prizes.
In 2009, UMGCC received cancer center designation from the National Cancer Institute in recognition of our outstanding clinical and basic research. US News and World Report also ranked UMGCC 33rd out of more than 900 cancer centers in the United States for 2009.
In response to the growth of our faculty and patient volumes, we are undergoing an expansion of our facilities. We have opened a new outpatient pavillion, the Roslyn and Leonard Stoler Pavillion, and we are remodeling and expanding our inpatient facilities. Our laboratory space is being extensively remodeled and a new biotechnology park has been constructed on the UMB campus, so that our research capacities can continue to expand.
We think this environment is an exceptional place for fellowship training. At UMGCC we offer the combination of superb clinical trialists, dedicated clinician-educators and cutting-edge basic science researchers in state of the art facilities, making our institution an outstanding place for oncologists-in-training.
Thank you for your interest in our institution, and we look forward to your visit.
Kevin J. Cullen, M.D.
University of Maryland Greenebaum Cancer Center